DOXYVA technology is a fast, reliable and effective approach for boosting
circulation and promoting wellness for patients with diabetes and varicose
veins. An interview with key opinion leader Dr. Ito Puruhito.
Effective O2 and nutrient distribution from our lungs and guts to
our organ tissues depends on micro-circulation. Micro-circulation
is where the vascular system allows the intravascular volume to
interact with the extravascular space to deliver O2 and nutrients
and in exchange pick up metabolic waste. When these physical
processes are interrupted, our body becomes stressed.
Physiologic stress is useful and essential for our survival. For
example, when we are sick it plays a crucial role in recruiting the
immune cell protagonists to help us overcome infections and
sickness. But when the stress transforms from a transitory state to
a permanent state, our body loses the capacity to self-heal and
achieves homeostasis over time. DOXYVA technology and its
revolutionary CO2 transdermal delivery allow our body to regain
proper micro-circulation blood flow to our organs.
One of the most common public health problems related with poor
microcirculation is diabetic foot ulcers. Diabetic foot ulcers are a
healthcare problem that affects more than 6.5 million patients in
the USA alone. It is expected that 15% of this population are at
risk of developing diabetic ulcers. Further epidemiological studies
have identified that almost 25% of diabetic patients are at risk of
lower extremity amputation and foot ulcers preceded 85% of all
amputations.
Diabetic patients with concomitant foot ulcers represent a per-
patient annual health-care cost that ranges between $12,000 and
$17,000. Nationally the USA spends $13 billion in healthcare
management of diabetic foot ulcers complication in addition to
the expenses associated with diabetes itself.
To help our community to better understand the disease and the
new proposed technology for improving diabetic patients quality
of life, we interviewed Prof. Ito Puruhito, a world renowned
cardio-thoracic surgeon based in Indonesia who has shared his
knowledge at several top universities including Harvard. Prof.
Puruhito has focused his research and efforts on better
understanding micro-circulation, particularly in the wound
healing process.
In our interview, Prof. Puruhito pointed out the importance of
micro-circulation health literacy among diabetic patients. He
stated: The better the circulation, the better the body can function
in general. Micro-circulation delivers blood and oxygen directly
to tissue, and when it is impaired, virtually every bodily function
suffers. Improving micro-circulationespecially in ulcers
developed in diabetic patientsleads to improved treatment
response, shorter healing time, and ulcer prevention. In other
words, it will improve patient quality of life and may prevent
extremity amputation. Prof. Puruhito has dedicated the last 50
years to researching how to improve microcirculation in his
patients. During this time he tested several strategies and products
Special thanks to Prof. Puruhito for allowing us to perform the interview at the International Wound Care and Biotherapy Conference in Kuala Lumpur (2015).
Dr. Ito Puruhito is a cardiothoracic surgeon with more than 50 years of experience and Professor of Surgery at Airlangga University Medical School in Surabaya,
Indonesia.
This article was published thanks to: Circularity Healthcare - DOXYVA, interviewer: Dr. Paul Kirkitelos.
intended to improve micro-circulation and found DOXYVA
technology to be the most efficient medical device.
Prof. Puruhito stated: The
DOXYVA technology caught
my attention because of its
remarkable ability to deliver such
a high concentration of CO2
directly to the bloodstream. He
also said: The ability to interact
directly with dermal capillary and
cellular receptors near the skin
gives it the ability to produce the
desired systemic effects, which is
critical for improving micro-
circulation and wound healing.
Prof. Puruhito is part of the DOXYVA independent researcher
team. He has been studying DOXYVAs positive impact on his
patients and has documented a remarkable success rate with
difficult-to-treat wounds and diabetic ulcers. Also, his preliminary
findings indicate clear improvements in health care indicators
such as peripheral O2 concentration and perfusion indexes among
his patients (scientific article pending for publication). Shortly
after he recognized DOXYVAs healthcare benefits for general
body health, he started to use DOXYVA on a daily basis and
said: As a researcher, it is one thing to observe results in your
patients, but another to experience them in your body. With
DOXYVAs transdermal technology, I had both!
DOXYVAs consistent positive impact in improving micro-
circulation and health quality is leading to new treatment options
for other pathologies such as varicose veins and cellulite, among
others. We are confident that DOXYVA technology and
effective transdermal delivery of CO2 will continue to prove its
capacity to help the body improve its micro-circulation and its
capacity to self-heal and achieve homeostasis.
Bibliography
Chandan K. Sen, P. G. (2003, NovDec). Human Skin Wounds: A Major
and Snowballing Threat to Public Health and the Economy.
Wound Repair Regen., 17(6), 763771.
Doupis, K. A. (2012). Management of Diabetic foot ulcer . Diabetes Ther.
McCall, B. (2014, march 13). Medscape. Retrieved from Medscape/News
& Perspective .